Intense Pulsed Light Improves Facial Telangiectasia and Acne‐Induced Post‐Inflammatory Erythema in Systemic Lupus Erythematosus Patient: A Case Report

Background Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease. Standard treatment typically involves corticosteroids, antimalarials, and immunosuppressants; however, long‐term corticosteroid use can lead to adverse cutaneous effects, including facial telangiectasia and acne vulgaris. While medical management often addresses active acne, residual telangiectasia and post‐inflammatory erythema (PIE) frequently persist as challenging cosmetic concerns. Aim To study the efficacy of intense pulsed light (IPL) in treating facial telangiectasia and PIE in patients with SLE; to record the possible adverse reactions of this treatment. Methods We present a case of a 21‐year‐old female SLE patient with facial telangiectasia and PIE. The treatment protocol incorporated five sessions of IPL therapy using dual‐band vascular filters (530–650 nm and 900–1200 nm) along with a 590 nm filter. Results After five sessions of IPL treatment, the facial telangiectasia and PIE of the patient were improved. During the 6‐month follow‐up period, no adverse reactions and worsening of SLE were observed. Conclusions Low‐energy IPL may be a safe and effective therapeutic option for managing steroid‐induced telangiectasia and acne‐related PIE in SLE patients.